Differentially Expressed Circular RNA Profile in an Intracranial Aneurysm Group Compared with a Healthy Control Group

Yonggang Ma1,2,3, Baoqing Zhang4, Dong Zhang1,2,3

  • 1Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

Disease Markers
|February 12, 2021
PubMed

Insights

Circular RNAs (circRNAs) show altered expression in intracranial aneurysms (IA). This study identifies circRNA profiles and suggests the mTOR pathway as a potential therapeutic target for IA, a condition causing fatal subarachnoid hemorrhage.

Area of Science:

  • Vascular Biology
  • Molecular Biology
  • Genomics

Background:

  • Intracranial aneurysm (IA) is a life-threatening condition characterized by vascular rupture and subarachnoid hemorrhage.
  • Circular RNAs (circRNAs) are implicated as potential biomarkers, but their role in IA pathogenesis is not understood.

Purpose of the Study:

  • To investigate the role of circRNA expression profiling in the development of intracranial aneurysms.
  • To identify potential diagnostic biomarkers and therapeutic targets for IA.

Main Methods:

  • Differential circRNA expression analysis was performed on blood samples from IA patients and healthy controls.
  • Microarray data validation was conducted using quantitative real-time polymerase chain reaction (qRT-PCR).
  • Bioinformatic analyses, including miRNA target prediction and Gene Ontology (GO) analysis, were employed.

Main Results:

  • A total of 235 differentially expressed circRNAs were identified between IA patients and controls, with 150 upregulated and 85 downregulated.
  • Five specific miRNAs were found to interact with differentially expressed circRNAs.
  • Gene Ontology analysis highlighted "Homophilic cell adhesion" and "Positive regulation of cellular process" as key functions associated with targeted genes.

Conclusions:

  • CircRNA expression profiling provides insights into the molecular mechanisms underlying IA formation.
  • The mammalian target of rapamycin (mTOR) pathway emerges as a potential therapeutic target for treating intracranial aneurysms.
Abstract